FindTrial
Sign In

Changes of flow in Arterial anastomosis of Free flap after the Intraoperative administration of Alprostadil

A Clinical Trial to Evaluate the Changes of Blood flow in Arterial anastomosis of Free flap after the Intraoperative administration of Alprostadil (Eglandin®) using Duplex ultrasonography in Patients who undergoing Free flap transfer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0002166
Enrollment
44
Registered
2016-12-09
Start date
2016-12-13
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Plan to recieve free flap transfer under general anesthesia 2. Age: >=18 and <80 years old 3. Administration of alprostadil during surgery 4. Volunteer, who are provided written informed consent prior to study participation.

Exclusion criteria

Exclusion criteria: 1. Refuse the participation of study 2. >= American society of anesthesiologist physical status IV 3. History of diabetes mellitus 4. History of chronic renal failure 5. History of peripheral vascular disease or hyperlipidemia 6. Use of any vasopressor or inotropics for hemodynamic instability before participation of study 7. Inappropriate subjects who are identified by researchers

Design outcomes

Primary

MeasureTime frame
blood flow in anastomosis-site—

Secondary

MeasureTime frame
survival of free flap—

Countries

Korea, Republic of

Contacts

Public ContactSeok-Joon Jin

Asan Medical Center

cerebellum@amc.seoul.kr+82-2-3010-3868

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026